Navigating Global Development Pathways Across US, Europe, & China to Maximize Competitiveness in Autoimmune Cell Therapy

• Comparing cross-border development pathways to accelerate speed-to-clinic and improve program execution
• Evaluating partnership versus independent strategies to balance access and IP control
• Addressing regulatory and geopolitical challenges to strengthen global competitiveness

Speakers:

Ed Zhang

Co-Founder & Chief Executive Officer

Overland Pharmaceuticals